论文部分内容阅读
目的探讨中西医结合治疗小儿支原体肺炎90例患儿的临床疗效。方法将2014年1月~2016年12月在我院进行治疗的90例支原体肺炎患儿作为研究对象,并将其按照随机数字法分成观察组45例与对照组45例,观察组患儿给予中西医结合治疗,对照组患儿给予单一的西医治疗,分别对两组患儿的临床治疗效果、症状消失时间、炎症指标变化及不良反应情况进行统计对比。结果观察组患儿的临床治疗效果明显高于对照组;观察组患儿的症状消失时间明显短于对照组;观察组患儿的炎症指标明显低于对照组;两组患儿均未出现较严重的不良反应。结论中西医结合治疗支原体肺炎疗效显著,比单一的西医治疗起效更快、疗效更高,且安全有保障,应用前景广阔,值得临床的推广及应用。
Objective To investigate the clinical efficacy of integrated traditional Chinese and western medicine in the treatment of 90 children with mycoplasma pneumonia. Methods Ninety children with mycoplasma pneumonia who were treated in our hospital from January 2014 to December 2016 were selected as study subjects and divided into 45 cases in observation group and 45 cases in control group according to random number method. Integrative medicine, the control group of children given a single Western medical treatment, respectively, the clinical efficacy of two groups of children, the disappearance of symptoms, changes in inflammatory markers and adverse reactions for statistical comparison. Results The clinical efficacy of observation group was significantly higher than that of control group. The symptom disappearance time in observation group was significantly shorter than that in control group. Inflammation index in observation group was significantly lower than that in control group. Serious adverse reactions. Conclusion The treatment of mycoplasma pneumonia with traditional Chinese and western medicine has a significant effect, which is faster, more effective, more safe and more secure than single Western medicine treatment. It has wide application prospect and is worthy of popularization and application.